Cumulative evidence for associations between matrix metalloproteinase-1, -3 and -8 variants and cancer risk.

IF 2.1 4区 医学 Q3 ONCOLOGY
Oncology Letters Pub Date : 2026-05-07 eCollection Date: 2026-07-01 DOI:10.3892/ol.2026.15640
Suqin Xu, Xianping Liu, Chenglu Huang
{"title":"Cumulative evidence for associations between matrix metalloproteinase-1, -3 and -8 variants and cancer risk.","authors":"Suqin Xu, Xianping Liu, Chenglu Huang","doi":"10.3892/ol.2026.15640","DOIUrl":null,"url":null,"abstract":"<p><p>Matrix metalloproteinase (MMP) gene polymorphisms have been implicated in cancer susceptibility; however, the results from previous studies have been inconsistent across populations and tumor types. The present study aimed to systematically evaluate the associations between MMP-1, MMP-3 and MMP-8 polymorphisms and cancer risk through a comprehensive meta-analysis. A total of 36,368 cancer cases and 40,246 controls from eligible studies were included. Pooled odds ratios and 95% confidence intervals were calculated to assess the associations between selected MMP polymorphisms and cancer risk. Venice criteria and false-positive report probability were applied to evaluate the cumulative evidence. Subgroup analyses according to ethnicity, genetic model and cancer type were conducted. Functional annotation was also integrated to explore potential biological mechanisms. In total, three polymorphisms (MMP-3 rs35068180, MMP-3 rs3025058 and MMP-1 rs1799750) were found to be significantly associated with the risk of seven types of cancer. Of these, strong evidence was assigned to two single nucleotide polymorphisms for three cancer risks (four associations), including MMP-3 rs3025058 with esophageal cancer in all populations under the dominant model, MMP-1 rs1799750 with glioblastoma in all populations under the recessive model and MMP-1 rs1799750 with renal cancer in all populations under both the recessive and allelic models. A total of six associations showed moderate evidence, while 14 were classified as weak. Notably, the effect sizes and statistical significance varied by ethnicity, genetic model and cancer type, suggesting context-dependent and population-specific effects. Functional annotation indicated that key variants may affect gene expression and tumor biology via regulation of promoter or enhancer activity. No significant association was observed between MMP-8 polymorphisms and cancer risk. The findings provide new insights into the complexity of gene-environment interactions underlying cancer susceptibility. This comprehensive meta-analysis highlights the complex, context-dependent associations of MMP-1, MMP-3 and MMP-8 polymorphisms with cancer risk. The results of the present study underscore the need for large, multi-ethnic studies and integrated genomic, functional and environmental analyses to clarify the roles of MMP variants in cancer development and to identify high-risk populations for precision prevention.</p>","PeriodicalId":19503,"journal":{"name":"Oncology Letters","volume":"32 1","pages":"286"},"PeriodicalIF":2.1000,"publicationDate":"2026-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13184938/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology Letters","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3892/ol.2026.15640","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Matrix metalloproteinase (MMP) gene polymorphisms have been implicated in cancer susceptibility; however, the results from previous studies have been inconsistent across populations and tumor types. The present study aimed to systematically evaluate the associations between MMP-1, MMP-3 and MMP-8 polymorphisms and cancer risk through a comprehensive meta-analysis. A total of 36,368 cancer cases and 40,246 controls from eligible studies were included. Pooled odds ratios and 95% confidence intervals were calculated to assess the associations between selected MMP polymorphisms and cancer risk. Venice criteria and false-positive report probability were applied to evaluate the cumulative evidence. Subgroup analyses according to ethnicity, genetic model and cancer type were conducted. Functional annotation was also integrated to explore potential biological mechanisms. In total, three polymorphisms (MMP-3 rs35068180, MMP-3 rs3025058 and MMP-1 rs1799750) were found to be significantly associated with the risk of seven types of cancer. Of these, strong evidence was assigned to two single nucleotide polymorphisms for three cancer risks (four associations), including MMP-3 rs3025058 with esophageal cancer in all populations under the dominant model, MMP-1 rs1799750 with glioblastoma in all populations under the recessive model and MMP-1 rs1799750 with renal cancer in all populations under both the recessive and allelic models. A total of six associations showed moderate evidence, while 14 were classified as weak. Notably, the effect sizes and statistical significance varied by ethnicity, genetic model and cancer type, suggesting context-dependent and population-specific effects. Functional annotation indicated that key variants may affect gene expression and tumor biology via regulation of promoter or enhancer activity. No significant association was observed between MMP-8 polymorphisms and cancer risk. The findings provide new insights into the complexity of gene-environment interactions underlying cancer susceptibility. This comprehensive meta-analysis highlights the complex, context-dependent associations of MMP-1, MMP-3 and MMP-8 polymorphisms with cancer risk. The results of the present study underscore the need for large, multi-ethnic studies and integrated genomic, functional and environmental analyses to clarify the roles of MMP variants in cancer development and to identify high-risk populations for precision prevention.

基质金属蛋白酶-1、-3和-8变异与癌症风险之间关联的累积证据
基质金属蛋白酶(MMP)基因多态性与癌症易感性有关;然而,先前的研究结果在人群和肿瘤类型中并不一致。本研究旨在通过综合荟萃分析,系统评估MMP-1、MMP-3和MMP-8多态性与癌症风险之间的关系。共有36,368例癌症病例和40,246例符合条件的对照纳入研究。计算合并优势比和95%置信区间,以评估选定的MMP多态性与癌症风险之间的关联。采用威尼斯标准和假阳性报告概率评价累积证据。根据种族、遗传模型和癌症类型进行亚组分析。功能注释也被用于探索潜在的生物学机制。总共发现3个多态性(MMP-3 rs35068180、MMP-3 rs3025058和MMP-1 rs1799750)与7种癌症的风险显著相关。其中,强有力的证据表明,两种单核苷酸多态性与三种癌症风险(四种关联)有关,包括MMP-3 rs3025058在所有显性模型下与食管癌有关,MMP-1 rs1799750在所有隐性模型下与胶质母细胞瘤有关,以及MMP-1 rs1799750在所有隐性和等位基因模型下与肾癌有关。共有6项关联显示出中等程度的证据,而14项被归类为弱关联。值得注意的是,效应大小和统计显著性因种族、遗传模型和癌症类型而异,表明环境依赖和人群特异性效应。功能注释表明,关键变异可能通过调控启动子或增强子活性来影响基因表达和肿瘤生物学。未观察到MMP-8多态性与癌症风险之间的显著关联。这些发现为癌症易感性背后的基因-环境相互作用的复杂性提供了新的见解。这项综合荟萃分析强调了MMP-1、MMP-3和MMP-8多态性与癌症风险之间复杂的、依赖于环境的关联。本研究的结果强调需要进行大规模、多种族的研究,以及整合基因组、功能和环境分析,以阐明MMP变异在癌症发展中的作用,并确定精确预防的高危人群。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Oncology Letters
Oncology Letters ONCOLOGY-
CiteScore
5.70
自引率
0.00%
发文量
412
审稿时长
2.0 months
期刊介绍: Oncology Letters is a monthly, peer-reviewed journal, available in print and online, that focuses on all aspects of clinical oncology, as well as in vitro and in vivo experimental model systems relevant to the mechanisms of disease. The principal aim of Oncology Letters is to provide the prompt publication of original studies of high quality that pertain to clinical oncology, chemotherapy, oncogenes, carcinogenesis, metastasis, epidemiology and viral oncology in the form of original research, reviews and case reports.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书